Kirin (OTCMKTS:KNBWY) Issues Quarterly Earnings Results

Kirin (OTCMKTS:KNBWY) announced its quarterly earnings data on Wednesday. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.09, Zacks reports. The company had revenue of $3.99 billion during the quarter, compared to analyst estimates of $4.04 billion. Kirin had a net margin of 7.79% and a return on equity of 12.22%.

Kirin Price Performance

Shares of OTCMKTS KNBWY opened at $18.71 on Thursday. The company has a current ratio of 1.48, a quick ratio of 1.02 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $15.16 billion, a price-to-earnings ratio of 12.29 and a beta of 0.05. Kirin has a twelve month low of $14.66 and a twelve month high of $20.21. The business has a 50 day simple moving average of $18.39 and a 200-day simple moving average of $17.38.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Kirin from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 29th. One research analyst has rated the stock with a Hold rating. According to MarketBeat, the stock currently has a consensus rating of “Hold”.

Kirin Company Profile

Kirin Holdings Company, Limited is a Japanese company with businesses in beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks and other nonalcoholic products, with brands sold in Japan and international markets. The company traces its roots to the Japan Brewery Company, established in 1885, and adopted the Kirin Brewery name in 1907. Today, its pharmaceutical business includes Kyowa Kirin, which develops and sells medicines, while its health science activities include products such as supplements and functional foods.